FAST NEWS: Ehang shares suspended pending major announcement
The latest: Autonomous aerial vehicle (AAV) maker EHang Holdings Ltd. (EH.US) said on Monday that the Nasdaq agreed to temporarily suspend trading in its American depositary shares (ADSs) until as…
FAST NEWS: Cango announces new $50 million share buyback
The Latest: Car-trading platform operator Cango Inc. (CANG.US) announced a plan last Friday to buy back up to $50 million worth of its American depositary shares (ADSs). Looking Up: The…
Bilibili Trades on Strong Name in Debt-for-Shares Swap
The popular video site sold $409 million in new shares ahead of its fourth-quarter results release, and will use part of the proceeds to buy back debt coming due in…
FAST NEWS: H World Raises $260 Million in Share Placement
The latest: Hotelier H World Group Ltd. (HTHT.US; 1179.HK) on Tuesday announced it will raise $260 million by selling 6.19 million American depositary shares (ADSs), or about 1.95% of its enlarged share capital,…
FAST NEWS: Agora Announces Founder Share Purchase Plan, New CTO
The latest: Agora Inc. (API.US), a provider of real-time engagement (RTE) technologies, on Wednesday said its founder and CEO Tony Zhao would buy up to $30 million worth of the…
FAST NEWS: Legend Biotech Plans $250 Million ADS Public Offering
The latest: Genscript Biotech Corp. (1548.HK) announced its New York-listed subsidiary, Legend Biotech Corp. (LEGN.US), plans to conduct a public offering of $250 million worth of American Depository Shares (ADS).…
FAST NEWS: Miniso Raises Only $72 Million With Conservative IPO Pricing
The latest: Miniso Group Holding Ltd. (MNSO.US), a Chinese retailer plans a secondary share listing in Hong Kong on July 13 to complement its existing U.S. listing, announced Wednesday it has…
Recent Articles
RELATED ARTICLES
-
FAST NEWS: EHang’s aerial vehicle approved for production
EH.US -
FAST NEWS: EHang’s aerial vehicle gets world’s first regulatory approval
EH.US
-
Industry woes chip away at ASMPT, with little relief in sight
0522.HK
-
Will Junshi Bio’s loss-making headaches ease with landmark U.S. drug approval?
1877.HK 688180.SHG
